ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/18/2026
Back to search
Official data from USPTO
OCEANSIDE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OCEANSIDE PHARMACEUTICALS
ST13
US500000077031338Class
5
Filing
77031338
Registration
3281693
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
02/19/2026
Trademark type
Word
Nice classes
5
Filing date
10/27/2006
Registration date
08/21/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/07/2017
Last transaction
02/19/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2004-03-00
First use in commerce
2004-03-00
Drawing code
4
Owner type
03
Owner location
Bridgewater, NJ
Examiner
SHARMA, NAPOLEON
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
OceanSide Pharmaceuticals, Inc.
OceanSide Pharmaceuticals, Inc.
Representatives
Robert J. Gorman
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer and dermatological disorders
Publications
History of USPTO decisions and trademark events.
42 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/11/2026
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/16/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/28/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/14/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/23/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/09/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/16/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/25/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/07/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/07/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/07/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/07/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
07/27/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/21/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/21/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/17/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/17/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2012
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/01/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/28/2012
E815
TEAS SECTION 8 & 15 RECEIVED
09/28/2012
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/23/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/19/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
08/21/2007
PUBO
PUBLISHED FOR OPPOSITION
06/05/2007
NPUB
NOTICE OF PUBLICATION
05/16/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/09/2007
ALIE
ASSIGNED TO LIE
04/09/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
03/16/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
03/16/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/16/2007
DOCK
ASSIGNED TO EXAMINER
03/08/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/22/2007
MPMK
NOTICE OF PSEUDO MARK MAILED
11/01/2006
NWAP
NEW APPLICATION ENTERED
10/31/2006
Continuous trademark protection
Get notified about every new filing that threatens OCEANSIDE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.